Cervomed Inc (CRVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CRVO | AMGN | VRTX | BMY | GILD |
| Company | Cervomed Inc | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 8.54 | 279.00 | 464.81 | 58.82 | 91.44 |
| High | 10.29 | 282.69 | 470.42 | 59.51 | 92.90 |
| Low | 8.26 | 278.00 | 462.01 | 58.78 | 91.44 |
| Last | 9.11 | 279.94 | 465.95 | 59.31 | 92.71 |
| Change | +1.13 | -0.07 | -1.12 | +0.57 | +1.36 |
| % Change | +14.16% | -0.02% | -0.24% | +0.97% | +1.49% |
| Volume | 547,266 | 4,846,357 | 575,522 | 3,023,645 | 2,206,422 |
| 20-Day Average Volume | 109,044 | 4,042,463 | 1,450,047 | 12,309,041 | 7,411,792 |
| Previous Close | 7.98 | 280.01 | 467.07 | 58.74 | 91.35 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 11.06 | 301.58 | 476.50 | 57.22 | 91.41 |
| 20-Day Raw Stochastic | 20.52% | 32.15% | 26.82% | 76.26% | 50.35% |
| 20-Day Relative Strength | 36.21% | 33.84% | 46.83% | 63.01% | 59.59% |
| Weighted Alpha | -63.52 | -4.45 | +23.65 | +28.28 | +28.47 |
| Today's Opinion | 100% Sell | 72% Sell | 8% Sell | 100% Buy | 100% Buy |
| Previous Opinion | 100% Sell | 72% Sell | 8% Sell | 100% Buy | 96% Buy |
| Last Month's Opinion | 88% Sell | 8% Buy | 8% Buy | 72% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.98% since 11/20/24 | -2.58% since 11/20/24 | +3.07% since 11/20/24 | +2.44% since 11/20/24 | +4.41% since 11/20/24 |
| Low | 7.75 on 11/26/24 | 257.80 on 11/26/24 | 445.00 on 11/21/24 | 57.47 on 11/21/24 | 88.07 on 11/21/24 |
| High | 10.30 on 11/22/24 | 297.32 on 11/25/24 | 470.42 on 11/27/24 | 60.68 on 11/25/24 | 92.89 on 11/27/24 |
| 1-Month | |||||
| %Chg | -33.14% since 10/25/24 | -11.52% since 10/25/24 | -2.64% since 10/25/24 | +14.20% since 10/25/24 | +3.97% since 10/25/24 |
| Low | 7.75 on 11/26/24 | 257.80 on 11/26/24 | 445.00 on 11/21/24 | 51.81 on 10/28/24 | 86.08 on 11/19/24 |
| High | 14.62 on 10/31/24 | 328.25 on 11/08/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | -45.05% since 08/27/24 | -14.22% since 08/27/24 | -3.17% since 08/27/24 | +23.22% since 08/27/24 | +20.18% since 08/27/24 |
| Low | 7.75 on 11/26/24 | 257.80 on 11/26/24 | 445.00 on 11/21/24 | 47.55 on 09/09/24 | 77.23 on 08/28/24 |
| High | 20.63 on 09/13/24 | 339.17 on 09/23/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | -50.99% since 05/24/24 | -8.30% since 05/24/24 | +1.78% since 05/24/24 | +43.78% since 05/24/24 | +40.89% since 05/24/24 |
| Low | 7.75 on 11/26/24 | 257.80 on 11/26/24 | 435.57 on 05/30/24 | 39.35 on 07/05/24 | 62.07 on 05/31/24 |
| High | 22.57 on 06/20/24 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 49,241 | 150,514,624 | 120,284,072 | 119,135,120 | 113,846,400 |
| Shares Outstanding, K | 6,170 | 537,533 | 257,529 | 2,028,177 | 1,246,266 |
| Annual Sales | 7,140,000 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 27,116,000,000 |
| Annual Net Income | -2,170,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 5,665,000,000 |
| Last Quarter Sales | 1,940,000 | 8,503,000,000 | 2,771,900,000 | 11,892,000,000 | 7,545,000,000 |
| Last Quarter Net Income | -4,750,000 | 2,830,000,000 | 1,045,400,000 | 1,211,000,000 | 1,253,000,000 |
| 60-Month Beta | 1.63 | 0.60 | 0.39 | 0.44 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.55 on 11/12/24 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 11/11/24 | 10/30/24 | 11/04/24 | 10/31/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | N/A | 0.600 on 10/04/24 | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | N/A | 10/04/24 | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.57 | 0.00 | 50.21 | 20.62 |